Related Experiment Video

Updated: Jun 21, 2026

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
13:01

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy

Published on: September 28, 2019

[Analysis of pancreatic leaking-related risk factors after pancreaticoduodenectomy]

Xin Li1, Ming Dong, Jian-ping Zhou

  • 1Department of General Surgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|July 21, 2009
PubMed

Insights

High preoperative serum total bilirubin is a risk factor for pancreatic fistula after pancreaticoduodenectomy (PD). Postoperative somatostatin use protects against this complication.

Area of Science:

  • Gastroenterology and Hepatology
  • Surgical Oncology
  • Clinical Research

Context:

  • Pancreaticoduodenectomy (PD) is a complex surgical procedure with a significant risk of postoperative pancreatic fistula.
  • Identifying modifiable risk factors and protective measures is crucial for improving patient outcomes after PD.

Purpose:

  • This study aimed to identify key risk factors associated with pancreatic fistula following pancreaticoduodenectomy.
  • The research also sought to determine protective factors that could mitigate the occurrence of pancreatic fistula.

Summary:

  • A retrospective analysis of 97 patients undergoing PD identified preoperative serum total bilirubin (higher levels) and operative time as significant risk factors for pancreatic fistula.
  • Multivariate analysis confirmed high preoperative serum total bilirubin (OR=11.687, P=0.021) as a major risk factor.
  • Postoperative prophylactic somatostatin use was identified as a significant protective factor (OR=0.056, P=0.020).

Impact:

  • Findings highlight the importance of preoperative bilirubin levels in risk assessment for PD.
  • The study suggests that postoperative somatostatin administration may be a valuable strategy to reduce pancreatic fistula rates.
  • This research contributes to optimizing patient management and reducing complications after pancreaticoduodenectomy.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: